Burcon NutraScience Corporation's stock surged by 4.76% in the last trading session, reflecting growing investor confidence.
Burcon NutraScience Corporation (BU.TO) saw its shares climb to CA$1.98, marking a notable increase of 4.76% in one trading day. This rise comes after impressive third-quarter results and a strong outlook for the company's production capabilities.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Burcon NutraScience Corporation
BU.TO
BU.TO
Burcon NutraScience Corporation
WealthAwesomeMarket cap
$23.74M
52W high
$3.00
52W low
$1.51
1W change
-5.13%
Beta
2.93
Analyst Price Targets
Based on analyst covering BU
Wall Street analysts forecast BU stock price to rise 0.0% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.85
+0.0% Upside
Current Price
C$1.85
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BU's historical volatility
30-Day Vol
76.1%
Annualized
90-Day Vol
71.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.55
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.74 | C$1.34 โ C$2.27 |
| 60 trading days | C$1.64 | C$1.13 โ C$2.38 |
| 90 trading days | C$1.55 | C$0.98 โ C$2.44 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors are responding positively to Burcon's significant revenue growth and production expansion, indicating strong market interest in its innovative plant-based protein products.
4.76%
Burcon's stock price increased by 4.76%, reflecting strong investor sentiment following impressive quarterly results.
Bull case
The company reported an astonishing 1100% revenue increase year-over-year, driven by heightened demand and successful commercial production. With over 20 buying customers and plans for capacity expansion, Burcon is well-positioned for future growth.
Bear case
Despite the positive momentum, investors should remain cautious as the company has yet to achieve profitability, with a profit margin of 0. Future performance will depend on sustained demand and successful scaling of production.
Impressive Revenue Growth
Burcon recently announced its fiscal 2026 third-quarter results, showcasing a remarkable revenue increase to CA$739,000, up approximately 1100% from the previous year. This surge is attributed to increased commercial production and repeat customer orders, highlighting the growing demand for plant-based proteins.
Expansion Plans and Production Capacity
The company is not just resting on its laurels; Burcon has ramped up its average daily production by about 40% compared to the previous quarter. With over 20 buying customers, Burcon is evaluating additional capacity expansion to meet the rising demand for its innovative products, such as Peazazzยฎ C pea protein.
Market Outlook and Investor Sentiment
With a market cap of CA$23.99 million and a recent stock price close of CA$1.98, investors are taking notice of Burcon's strategic growth initiatives. The companyโs ability to scale production effectively and maintain strong customer relationships will be crucial for its future success. For more insights, check out our detailed analysis on Burcon NutraScience Corporation.
Advertisement
